✦ LIBER ✦

Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens

✍ Scribed by Huanfa Yi; Xiaofei Yu; Chunqing Guo; Masoud H. Manjili; Elizabeth A. Repasky; Xiang-Yang Wang

Book ID: 105967842
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 604 KB
Volume: 60
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-010-0939-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical trial: T-cell therapy f

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

✍ Murphy, G.; Tjoa, B.; Ragde, H.; Kenny, G.; Boynton, A. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

## BACKGROUND. Conventional treatment for metastatic prostate cancer have failed to demonstrate curative potential in all patients. Investigations involving the role of T-cell immunity in the clearance of neoplastic cells are now available. Development of T-cell immunotherapy may give a new approa

Report of immune monitoring of prostate

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

✍ Salgaller, Michael L.; Lodge, Patricia A.; McLean, Joanne G.; Tjoa, Ben A.; Loft 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## BACKGROUND. In this paper we describe our program for the immune monitoring of phase II participants given dendritic cell (DC)/prostate-specific membrane antigen (PSMA)-based immunotherapy, and we also present some initial findings. METHODS. Phase II subjects received six administrations of aut

Development of Gene Therapy Using Prosta

Development of Gene Therapy Using Prostate-specific Membrane Antigen Promoter/Enhancer with Cre Recombinase/LoxP System for Prostate Cancer Cells under Androgen Ablation Condition

✍ Ikegami, Shusei ;Tadakuma, Takushi ;Suzuki, Satoshi ;Yoshimura, Ichiro ;Asano, T 📂 Article 📅 2002 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 679 KB

Establishing human prostate cancer cell

Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines

✍ Tony T. Wu; Robert A. Sikes; Quanjun Cui; George N. Thalmann; Chinghai Kao; Cher 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 497 KB 👁 2 views

LNCaP lineage-derived human prostate cancer cell lines C4-2 and C4-2B 4 acquire androgen independence and osseous metastatic potential in vivo. Using C4-2 and C4-2B 4 the goals of the current investigation were 1) to establish an ideal bone xenograft model for prostate cancer cells in intact athymic